Identification of novel virus inhibitors by influenza A virus specific reporter cell based screening

Antiviral Research

Volumn 93, Issue 1, 2012, Pages 48-54

  Zhang, Junjie ^a,b   Liu, Ting ^a,b   Tong, Xiaomei ^a   Li, Gang ^a,b   Yan, Jinghua ^a   Ye, Xin ^a  

^a INSTITUTE OF MICROBIOLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Antiviral inhibitors; Cell line based screening; HA; Influenza A virus; VRNP

Indexed keywords

ANTIVIRUS AGENT; LUCIFERASE; NSC 103770; NSC 13248; NSC 150821; NSC 328104; NSC 332670; NSC 335506; NSC 36693; NSC 377384; NSC 50651; NSC 73735; RIBAVIRIN; RIBONUCLEOPROTEIN; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CELL LINE; CHEMICAL STRUCTURE; CONTROLLED STUDY; DRUG SCREENING; GENE LIBRARY; GENETIC SCREENING; HUMAN; HUMAN CELL; INFLUENZA VIRUS A; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H5N1; INFLUENZA VIRUS A H9N2; INFLUENZA VIRUS REPORTER CELL LINE; MEMBRANE FUSION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; VIRUS GENE; VIRUS INHIBITION; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; DOGS; GENES, REPORTER; HEK293 CELLS; HELA CELLS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS; MICROBIAL SENSITIVITY TESTS; SMALL MOLECULE LIBRARIES; VIRUS REPLICATION;

INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE;

EID: 84355162048     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2011.10.014     Document Type: Article

References (33)

1. Abdel-Ghafar A.N., Chotpitayasunondh T., Gao Z., Hayden F.G., Nguyen D.H., de Jong M.D., Naghdaliyev A., Peiris J.S., Shindo N., Soeroso S., Uyeki T.M. Update on avian influenza A (H5N1) virus infection in humans. N. Engl. J. Med. 2008, 358:261-273.
2. Baz M., Abed Y., Papenburg J., Bouhy X., Hamelin M.E., Boivin G. Emergence of oseltamivir-resistant pandemic H1N1 virus during prophylaxis. N. Engl. J. Med. 2009, 361:2296-2297.
3. Bright R.A., Medina M.J., Xu X., Perez-Oronoz G., Wallis T.R., Davis X.M., Povinelli L., Cox N.J., Klimov A.I. Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern. Lancet 2005, 366:1175-1181.
4. Bright R.A., Shay D.K., Shu B., Cox N.J., Klimov A.I. Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States. JAMA 2006, 295:891-894.
5. Dawood F.S., Jain S., Finelli L., Shaw M.W., Lindstrom S., Garten R.J., Gubareva L.V., Xu X., Bridges C.B., Uyeki T.M. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N. Engl. J. Med. 2009, 360:2605-2615.
6. de Clercq E. Antiviral agents active against influenza A viruses. Nat Rev Drug Discov 2006, 5:1015-1025.
7. De Jong M.D., Simmons C.P., Thanh T.T., Hien V.M., Smith G.J., Chau T.N., Hoang D.M., Chau N.V., Khanh T.H., Dong V.C., Qui P.T., Cam B.V., Ha do Q., Guan Y., Peiris J.S., Chinh N.T., Hien T.T., Farrar J. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat. Med. 2006, 12:1203-1207.
8. Deyde V.M., Xu X., Bright R.A., Shaw M., Smith C.B., Zhang Y., Shu Y., Gubareva L.V., Cox N.J., Klimov A.I. Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide. J. Infect. Dis. 2007, 196:249-257.
9. Dharan N.J., Gubareva L.V., Meyer J.J., Okomo-Adhiambo M., McClinton R.C., Marshall S.A., St George K., Epperson S., Brammer L., Klimov A.I., Bresee J.S., Fry A.M. Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States. JAMA 2009, 301:1034-1041.
10. Furuta Y., Takahashi K., Fukuda Y., Kuno M., Kamiyama T., Kozaki K., Nomura N., Egawa H., Minami S., Watanabe Y., Narita H., Shiraki K. In vitro and in vivo activities of anti-influenza virus compound T-705. Antimicrob. Agents Chemother. 2002, 46:977-981.
11. Furuta Y., Takahashi K., Kuno-Maekawa M., Sangawa H., Uehara S., Kozaki K., Nomura N., Egawa H., Shiraki K. Mechanism of action of T-705 against influenza virus. Antimicrob. Agents Chemother. 2005, 49:981-986.
12. Gambotto A., Barratt-Boyes S.M., de Jong M.D., Neumann G., Kawaoka Y. Human infection with highly pathogenic H5N1 influenza virus. Lancet 2008, 371:1464-1475.
13. Ghanem A., Mayer D., Chase G., Tegge W., Frank R., Kochs G., Garcia-Sastre A., Schwemmle M. Peptide-mediated interference with influenza A virus polymerase. J. Virol. 2007, 81:7801-7804.
14. Hao L., Sakurai A., Watanabe T., Sorensen E., Nidom C.A., Newton M.A., Ahlquist P., Kawaoka Y. Drosophila RNAi screen identifies host genes important for influenza virus replication. Nature 2008, 454:890-893.
15. Hurt A.C., Ernest J., Deng Y.M., Iannello P., Besselaar T.G., Birch C., Buchy P., Chittaganpitch M., Chiu S.C., Dwyer D., Guigon A., Harrower B., Kei I.P., Kok T., Lin C., McPhie K., Mohd A., Olveda R., Panayotou T., Rawlinson W., Scott L., Smith D., D'Souza H., Komadina N., Shaw R., Kelso A., Barr I.G. Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa. Antiviral Res 2009, 83:90-93.
16. Kao R.Y., Yang D., Lau L.S., Tsui W.H., Hu L., Dai J., Chan M.P., Chan C.M., Wang P., Zheng B.J., Sun J., Huang J.D., Madar J., Chen G., Chen H., Guan Y., Yuen K.Y. Identification of influenza A nucleoprotein as an antiviral target. Nat. Biotechnol. 2010, 28:600-605.
17. Karlas A., Machuy N., Shin Y., Pleissner K.P., Artarini A., Heuer D., Becker D., Khalil H., Ogilvie L.A., Hess S., Maurer A.P., Muller E., Wolff T., Rudel T., Meyer T.F. Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication. Nature 2010, 463:818-822.
18. Kiso M., Takahashi K., Sakai-Tagawa Y., Shinya K., Sakabe S., Le Q.M., Ozawa M., Furuta Y., Kawaoka Y. T-705 (favipiravir) activity against lethal H5N1 influenza A viruses. Proc. Natl Acad. Sci. USA 2010, 107:882-887.
19. Konig R., Stertz S., Zhou Y., Inoue A., Hoffmann H.H., Bhattacharyya S., Alamares J.G., Tscherne D.M., Ortigoza M.B., Liang Y., Gao Q., Andrews S.E., Bandyopadhyay S., De Jesus P., Tu B.P., Pache L., Shih C., Orth A., Bonamy G., Miraglia L., Ideker T., Garcia-Sastre A., Young J.A., Palese P., Shaw M.L., Chanda S.K. Human host factors required for influenza virus replication. Nature 2010, 463:813-817.
20. Lutz A., Dyall J., Olivo P.D., Pekosz A. Virus-inducible reporter genes as a tool for detecting and quantifying influenza A virus replication. J. Virol. Methods 2005, 126:13-20.
21. Meijer A., Lackenby A., Hungnes O., Lina B., van-der-Werf S., Schweiger B., Opp M., Paget J., van-de-Kassteele J., Hay A., Zambon M. Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season. Emerg. Infect. Dis. 2009, 15:552-560.
22. Moscona A. Medical management of influenza infection. Annu. Rev. Med. 2008, 59:397-413.
23. Moscona A. Global transmission of oseltamivir-resistant influenza. N. Engl. J. Med. 2009, 360:953-956.
24. Nakazawa M., Kadowaki S.E., Watanabe I., Kadowaki Y., Takei M., Fukuda H. PA subunit of RNA polymerase as a promising target for anti-influenza virus agents. Antiviral Res. 2008, 78:194-201.
25. Neumann G., Watanabe T., Ito H., Watanabe S., Goto H., Gao P., Hughes M., Perez D.R., Donis R., Hoffmann E., Hobom G., Kawaoka Y. Generation of influenza A viruses entirely from cloned cDNAs. Proc. Natl Acad. Sci. USA 1999, 96:9345-9350.
26. Severson W.E., McDowell M., Ananthan S., Chung D.H., Rasmussen L., Sosa M.I., White E.L., Noah J., Jonsson C.B. High-throughput screening of a 100, 000-compound library for inhibitors of influenza A virus (H3N2). J. Biomol. Screen. 2008, 13:879-887.
27. Su C.Y., Cheng T.J., Lin M.I., Wang S.Y., Huang W.I., Lin-Chu S.Y., Chen Y.H., Wu C.Y., Lai M.M., Cheng W.C., Wu Y.T., Tsai M.D., Cheng Y.S., Wong C.H. High-throughput identification of compounds targeting influenza RNA-dependent RNA polymerase activity. Proc. Natl Acad. Sci. USA 2010, 107:19151-19156.
28. Su Y., Yang H.Y., Zhang B.J., Jia H.L., Tien P. Analysis of a point mutation in H5N1 avian influenza virus hemagglutinin in relation to virus entry into live mammalian cells. Arch. Virol. 2008, 153:2253-2261.
29. Thompson W.W., Shay D.K., Weintraub E., Brammer L., Cox N., Anderson L.J., Fukuda K. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003, 289:179-186.
30. Van Riel D., Munster V.J., de Wit E., Rimmelzwaan G.F., Fouchier R.A., Osterhaus A.D., Kuiken T. H5N1 Virus Attachment to Lower Respiratory Tract. Science 2006, 312:399.
31. Vanderlinden E., Goktas F., Cesur Z., Froeyen M., Reed M.L., Russell C.J., Cesur N., Naesens L. Novel inhibitors of influenza virus fusion: structure-activity relationship and interaction with the viral hemagglutinin. J. Virol. 2010, 84:4277-4288.
32. Weinstock D.M., Zuccotti G. The evolution of influenza resistance and treatment. JAMA 2009, 301:1066-1069.
33. Zhang J., Li G., Liu X., Wang Z., Liu W., Ye X. Influenza A virus M1 blocks the classical complement pathway through interacting with C1qA. J. Gen. Virol. 2009, 90:2751-2758.